Study of advanced imaging to detect esophageal cancer spread
Part of Cancer, Digestive system clinical trials.
This trial uses advanced imaging tests (spectral CT, multimodal MRI, and FAPI PET-CT) before surgery to find if esophageal cancer has spread to lymph nodes. The goal is to improve how doctors predict and diagnose lymph node metastasis using these scans, along with pathology and AI analysis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with esophageal cancer through a biopsy.
- You must be scheduled for surgery to remove the cancer and nearby lymph nodes.
- You must have had or be willing to have multimodal MRI, spectral CT, and FAPI PET-CT scans before surgery.
- If you received chemotherapy or radiation before surgery, you must have these scans both before and after that treatment.
- You cannot have had any other cancer or cancer treatment in the past.
- You must not have any health issues that make MRI, CT, or PET-CT unsafe for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses CT and MRI scans before and after chemotherapy or radiation to see how well the treatment worked in esophageal cancer. The goal is to match scan results with what doctors find after surgery.
This study looks at whether detailed scans taken before treatment can predict how well chemo and immunotherapy will work for advanced esophageal cancer. The goal is to improve treatment planning and potentially reduce side effects by personalizing care.
This trial tests whether special fluorescent dyes attached to immune drugs can help doctors see esophageal cancer more clearly during an endoscopy. It may help guide treatment decisions.
This trial tests a new PET scan drug (18F-FAPI) to see if it can better detect where stomach or esophageal cancer has spread. It may help doctors plan the right treatment for you.
This Phase 1 study uses specialized imaging (including MRI) to better “see” low-oxygen areas in esophageal cancer and help guide individualized radiation treatment. It aims to improve how radiation is planned and delivered while checking safety.
This study uses detailed MRI scans to look at esophageal cancer before surgery. It helps doctors understand the tumor better and plan the best treatment. You may join if you are scheduled for surgery to remove the cancer.
Hear when a new Esophageal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.